Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Peptides to Body Recomposition Ranked: Efficacy Comparison

CJC-1295/Ipamorelin GHRH + GHRP synergy for pulsatile GH release 100mcg each, 1–2× daily Preserves insulin sensitivity while activating lipolysis and anabolism simultaneously Requires injection; effects dependent on natural GH reserve Highest efficacy for cont

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • CJC-1295/Ipamorelin
  • GHRH + GHRP synergy for pulsatile GH release
  • 100mcg each, 1–2× daily
  • Preserves insulin sensitivity while activating lipolysis and anabolism simultaneously
  • Requires injection; effects dependent on natural GH reserve
  • Highest efficacy for controlled recomposition research when paired with resistance training
  • MK-677 (Ibutamoren)
  • Ghrelin mimetic producing sustained GH and IGF-1 elevation
  • 12.5–25mg daily (oral)
  • 24-hour anabolic signalling supports muscle protein synthesis during deficits
  • Mild insulin resistance and water retention at higher doses
  • Best for lean mass preservation; requires carbohydrate cycling to optimise fat loss
  • Tesofensine
  • Triple monoamine reuptake inhibitor
  • 0.25–1mg daily
  • Increases resting energy expenditure 6–10%; direct fat mobilisation independent of hormonal pathways
  • No direct anabolic effect; fat loss only unless combined with training
  • Most effective for accelerating fat loss phase; must pair with adequate protein and training volume
  • Hexarelin
  • GHRP with additional CD36 receptor activation
  • 100–200mcg pre-workout
  • Enhanced intra-workout fat oxidation and nutrient partitioning
  • Desensitisation after 12–16 weeks; requires cycling
  • Ideal for acute recomposition phases; short-term use maximises effect without receptor downregulation
  • Lipo C (Lipotropic blend)
  • Methyl donor support for hepatic fat metabolism
  • 1ml IM, 1–3× weekly
  • Prevents hepatic steatosis during rapid fat mobilisation; supports VLDL assembly
  • No direct fat burning or muscle-building effect
  • Adjunct compound that optimises liver function during aggressive recomposition protocols